We are live on ! Find out more
WIA

Wealthstreet Investment Advisors Portfolio holdings

AUM $3.71M
1-Year Est. Return 13.1%
This Fund
S&P 500
This Quarter Est. Return
+12.13%
1 Year Est. Return
+13.1%
3 Year Est. Return
+75.79%
5 Year Est. Return
10 Year Est. Return
AUM
$857M
AUM Growth
+$74.4M
Cap. Flow
+$16.5M
Cap. Flow %
1.93%
Top 10 Hldgs %
25.43%
Holding
353
New
18
Increased
76
Reduced
99
Closed
3

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$14.8M
2
UNH icon
UnitedHealth
UNH
+$661K
3
CVX icon
Chevron
CVX
+$653K
4
NTNX icon
Nutanix
NTNX
+$554K
5
LLY icon
Eli Lilly
LLY
+$545K

Sector Composition

Rank Sector Weight
1 Healthcare 18.24%
2 Technology 15.78%
3 Financials 11.55%
4 Industrials 10.57%
5 Consumer Staples 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JJSF icon
226
J&J Snack Foods
JJSF
$1.66B
$553K 0.06%
3,000
DE icon
227
Deere & Co
DE
$171B
$537K 0.06%
3,100
CPB icon
228
Campbell Soup
CPB
$6.93B
$536K 0.06%
10,853
VGT icon
229
Vanguard Information Technology ETF
VGT
$145B
$534K 0.06%
17,440
SO icon
230
Southern Company
SO
$103B
$524K 0.06%
8,223
CTXS
231
DELISTED
Citrix Systems Inc
CTXS
$518K 0.06%
4,671
+1
+0% +$108
HYS icon
232
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.78B
$509K 0.06%
5,100
-173
-3% -$17.2K
HAL icon
233
Halliburton
HAL
$28.7B
$508K 0.06%
20,779
RDS.B
234
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$507K 0.06%
8,454
+475
+6% +$28K
HYLS icon
235
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.64B
$503K 0.06%
10,314
+2,250
+28% +$109K
CTVA icon
236
Corteva
CTVA
$55.3B
$502K 0.06%
16,999
-2,976
-15% -$78.8K
CBRE icon
237
CBRE Group
CBRE
$43.5B
$496K 0.06%
8,100
PRF icon
238
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
$479K 0.06%
+18,890
New +$460K
MS icon
239
Morgan Stanley
MS
$336B
$474K 0.06%
9,269
TIF
240
DELISTED
Tiffany & Co.
TIF
$468K 0.05%
3,500
DIM icon
241
WisdomTree International MidCap Dividend Fund
DIM
$171M
$463K 0.05%
7,040
+300
+4% +$19K
BSCM
242
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
$451K 0.05%
20,950
COP icon
243
ConocoPhillips
COP
$157B
$449K 0.05%
6,908
GSK icon
244
GSK
GSK
$103B
$440K 0.05%
7,488
BSCN
245
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$437K 0.05%
20,500
CSX icon
246
CSX Corp
CSX
$95.9B
$434K 0.05%
18,000
RSG icon
247
Republic Services
RSG
$68B
$427K 0.05%
4,767
BMY.RT
248
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$420K 0.05%
+139,313
New +$362K
TM icon
249
Toyota
TM
$227B
$417K 0.05%
2,969
-100
-3% -$14K
SNY icon
250
Sanofi
SNY
$109B
$411K 0.05%
8,192

Similar funds

Wealthstreet Investment Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Wealthstreet Investment Advisors held 353 positions worth $857M, up 9.5% from $783M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Wealthstreet Investment Advisors's Q4 2019 filing shows 18 new, 76 increased, 99 reduced and 3 closed positions. Its largest new stake was WisdomTree US SmallCap Dividend Fund: 20,012 shares worth $574K. The largest sale was Celgene Corp, an estimated $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Wealthstreet Investment Advisors's largest Q4 2019 buy was WisdomTree US SmallCap Dividend Fund: 20,012 shares worth $574K.
  • Wealthstreet Investment Advisors added most to Bristol-Myers Squibb in Q4 2019, an estimated $8.44M increase.
  • Wealthstreet Investment Advisors's biggest Q4 2019 reduction was UnitedHealth, cutting an estimated $661K.
  • Wealthstreet Investment Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $14.8M.
  • Wealthstreet Investment Advisors's ten largest holdings make up 25% of its $857M portfolio in Q4 2019.
  • Wealthstreet Investment Advisors opened 18 new positions and closed 3 in Q4 2019.
  • Wealthstreet Investment Advisors's portfolio value rose 9.5% quarter-over-quarter to $857M.

Based on Wealthstreet Investment Advisors's 13F filing for Q4 2019, filed 22 Jan 2020.